204 related articles for article (PubMed ID: 31192)
1. Blockade by N-methylhydroxylamine of activation of guanylate cyclase and elevations of guanosine 3',5'-monophosphate levels in nervous tissues.
Deguchi T; Saito M; Kono M
Biochim Biophys Acta; 1978 Nov; 544(1):8-19. PubMed ID: 31192
[TBL] [Abstract][Full Text] [Related]
2. Purification and properties of guanylate cyclase from the synaptosomal soluble fraction of rat brain.
Nakane M; Deguchi T
Biochim Biophys Acta; 1978 Jul; 525(1):275-85. PubMed ID: 28767
[TBL] [Abstract][Full Text] [Related]
3. Increased responsiveness of the hepatic guanylate cyclase-guanosine 3',5'-monophosphate system to nitrosoguanidine following partial hepatectomy.
Briggs RG; Derubertis FR
Biochim Biophys Acta; 1980 Apr; 628(4):425-37. PubMed ID: 6102869
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cerebellar guanylate cyclase using N-methyl-N'-nitro-N-nitrosoguanidine. Presence of two different types of guanylate cyclase in soluble and particulate fractions.
Yoshikawa K; Kuriyama K
Biochim Biophys Acta; 1980 Apr; 628(4):377-87. PubMed ID: 6102868
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations.
Arnold WP; Mittal CK; Katsuki S; Murad F
Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3203-7. PubMed ID: 20623
[TBL] [Abstract][Full Text] [Related]
6. Adenosine 3',5'-monophosphate formation by preparations of rat liver soluble guanylate cyclase activated with nitric oxide, nitrosyl ferroheme, S-nitrosothiols, and other nitroso compounds.
McNamara DB; Kadowitz PJ; Hyman AL; Ignarro LJ
Can J Physiol Pharmacol; 1980 Dec; 58(12):1446-56. PubMed ID: 6113040
[TBL] [Abstract][Full Text] [Related]
7. N-hydroxylamine is not an intermediate in the conversion of L-arginine to an activator of soluble guanylate cyclase in neuroblastoma N1E-115 cells.
Pou S; Pou WS; Rosen GM; el-Fakahany EE
Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):547-52. PubMed ID: 1671745
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of adenosine 3',5'-monophosphate by guanylate cyclase, a new pathway for its formation.
Mittal CK; Braughler JM; Ichihara K; Murad F
Biochim Biophys Acta; 1979 Jul; 585(3):333-42. PubMed ID: 39626
[TBL] [Abstract][Full Text] [Related]
9. Guanylate cyclase in neuroblastoma N1E 115 cells: presence of endogenous activator.
Amano E; Nakane M; Deguchi T
J Cyclic Nucleotide Res; 1979; 5(2):135-44. PubMed ID: 36417
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of N-methyl-N'-nitro-N-nitrosoguanidine-activated guanylate cyclase by anticarcinogenic agents.
Akiyama M; Kuo CH; Hayashi Y; Miki N
Gan; 1980 Jun; 71(3):356-61. PubMed ID: 6106617
[TBL] [Abstract][Full Text] [Related]
11. Cyclic GMP and cell death in rat cerebellar slices.
Garthwaite G; Garthwaite J
Neuroscience; 1988 Jul; 26(1):321-6. PubMed ID: 2901694
[TBL] [Abstract][Full Text] [Related]
12. Studies of N-methyl-N'-nitro-N-nitrosoguanidine action on the guanylate cyclase-guanosine 3'5' monophosphate system of isolated colonic epithelial cells.
Derubertis FR; Craven PA; Saito R
Cancer; 1980 Mar; 45(5 Suppl):1052-9. PubMed ID: 6101992
[No Abstract] [Full Text] [Related]
13. Properties of the guanylate cyclase-guanosine 3':5'-monophosphate system of rat renal cortex. Activation of guanylate cyclase and calcium-independent modulation of tissue guanosine 3':5'-monophosphate by sodium azide.
DeRubertis FR; Craven PA
J Biol Chem; 1976 Aug; 251(15):4651-8. PubMed ID: 7563
[TBL] [Abstract][Full Text] [Related]
14. Increased guanylate cyclase activity and guanosine 3',5'-monophosphate content in ethionine-induced hepatomas.
DeRubertis FR; Craven P
Cancer Res; 1977 Jan; 37(1):15-21. PubMed ID: 11887
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine.
Katsuki S; Arnold W; Mittal C; Murad F
J Cyclic Nucleotide Res; 1977 Feb; 3(1):23-35. PubMed ID: 14978
[TBL] [Abstract][Full Text] [Related]
16. Activation of the guanylate cyclase-guanosine 3'5' monophosphate system of colonic mucosa by n-methyl-n'-nitro-n-nitrosoguanidine.
DeRubertis FR; Craven PA
Cancer; 1977 Nov; 40(5 Suppl):2600-8. PubMed ID: 21743
[TBL] [Abstract][Full Text] [Related]
17. Guanylate cyclase and cyclic guanosine 3':5'-monophosphate phosphodiesterase activities and cyclic guanosine 3':5'-monophosphate levels in normal and transformed fibroblasts in culture.
Nesbitt JA; Anderson WB; Miller Z; Pastan I; Russell TR; Gospodarowicz D
J Biol Chem; 1976 Apr; 251(8):2344-52. PubMed ID: 4444
[TBL] [Abstract][Full Text] [Related]
18. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
Yu SM; Kuo SC
Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
[TBL] [Abstract][Full Text] [Related]
19. Electron spin resonance study of the role of NO . catalase in the activation of guanylate cyclase by NaN3 and NH2OH. Modulation of enzyme responses by heme proteins and their nitrosyl derivatives.
Craven PA; DeRubertis FR; Pratt DW
J Biol Chem; 1979 Sep; 254(17):8213-22. PubMed ID: 38248
[TBL] [Abstract][Full Text] [Related]
20. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
Fedele E; Jin Y; Varnier G; Raiteri M
Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
